Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Hochhaus A, Réa D, Boquimpani C, Minami Y, Cortes JE, Hughes TP, Apperley JF, Lomaia E, Voloshin S, Turkina A, Kim DW, Abdo A, Fogliatto LM, le Coutre P, Sasaki K, Kim DDH, Saussele S, Annunziata M, Chaudhri N, Chee L, García-Gutiérrez V, Kapoor S, Allepuz A, Quenet S, Bédoucha V, Mauro MJ. Hochhaus A, et al. Among authors: chaudhri n. Leukemia. 2023 Mar;37(3):617-626. doi: 10.1038/s41375-023-01829-9. Epub 2023 Jan 30. Leukemia. 2023. PMID: 36717654 Free PMC article. Clinical Trial.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Réa D, Mauro MJ, Boquimpani C, Minami Y, Lomaia E, Voloshin S, Turkina A, Kim DW, Apperley JF, Abdo A, Fogliatto LM, Kim DDH, le Coutre P, Saussele S, Annunziata M, Hughes TP, Chaudhri N, Sasaki K, Chee L, García-Gutiérrez V, Cortes JE, Aimone P, Allepuz A, Quenet S, Bédoucha V, Hochhaus A. Réa D, et al. Among authors: chaudhri n. Blood. 2021 Nov 25;138(21):2031-2041. doi: 10.1182/blood.2020009984. Blood. 2021. PMID: 34407542 Free PMC article. Clinical Trial.
Improved survival in adolescents and young adults (AYA) patients aged 14-55 years with acute lymphoblastic leukemia using pediatric-inspired protocol - a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center.
Hanbali A, Kotb A, Fakih RE, Alfraih F, Ahmed SO, Shaheen M, Alhayli S, Alahmari A, Alotaibi A, Alshaibani A, Riash MA, Deeba F, Asif M, Rasheed W, Alzahrani H, Alsharif F, Chaudhri N, Almohareb F, Aljurf M. Hanbali A, et al. Among authors: chaudhri n. Leuk Res Rep. 2021 Sep 24;16:100270. doi: 10.1016/j.lrr.2021.100270. eCollection 2021. Leuk Res Rep. 2021. PMID: 34631407 Free PMC article.
Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome.
Hanbali A, Kotb A, El Fakih R, Alfraih F, Ahmed SO, Shaheen M, Hashmi S, Alhayli S, Alahmari A, Riash MA, Rasheed W, Alzahrani H, Alsharif F, Chaudhri N, Almohareb F, Aljurf M. Hanbali A, et al. Among authors: chaudhri n. Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):670-677. doi: 10.1016/j.clml.2019.05.004. Epub 2019 May 16. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31377206
Leukemia during pregnancy: long term follow up of 32 cases from a single institution.
Saleh AJ, Alhejazi A, Ahmed SO, Al Mohareb F, AlSharif F, AlZahrani H, Mohamed SY, Rasheed W, AlDawsari G, Ibrahim K, Ahmed S, Chebbo W, ElGohary G, Almahayni M, Chaudhri N, Aljurf M. Saleh AJ, et al. Among authors: chaudhri n. Hematol Oncol Stem Cell Ther. 2014 Jun;7(2):63-8. doi: 10.1016/j.hemonc.2014.03.001. Epub 2014 May 9. Hematol Oncol Stem Cell Ther. 2014. PMID: 24816335 Free article.
184 results